Clinical outcomes after bypass grafting are adversely affected by the development of degenerative graft disease. The differences between vein grafts and arterial grafts regarding the susceptibility to atherosclerosis underscore the importance of local factors in the development of the disease. Thus the overall goal of this project is to clarify the cellular mechanisms which confer the susceptibility to atherosclerosis in these types of vascular grafts. Two hypotheses are put forward. Hypothesis 1. Different mechanisms of repair in remodeling are proposed for the two types of grafts. The arterialization of veins activates highly reactive fibroblasts where as arterial grafts undergo the repair process by smooth muscle cells. The formation of atherosclerotic lesions will be compared in venous and arterial grafts in a pig model. Experiments in vivo will determine cell activation, intravascular lipids, and foam cells throughout graft remodeling. The expression of proteoglycans and enzymes regulating their side chain assembly as well as lipoprotein lipase will be characterized. Differences between isolated fibroblasts and medial smooth muscle cells regarding cell function will be assessed. Hypothesis 2. The differences in cellular mechanism of vascular remodeling determine the retention and catabolism of atherogenic lipoproteins in these two types of vascular grafts. The retention of radiolabelled LDL will be compared between venous and arterial grafts. The role of isolated proteoglycans and the composition of glycosaminoglycan chains will be studied with regard to their binding affinities to LDL. Vascular fibroblasts and smooth muscle cells will be characterized in vitro regarding mechanisms of LDL retention as well as catabolism. Thus this proposal examines putative mechanisms responsible for graft attrition in relation to cellular heterogeneity of the vessel.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060672-03
Application #
6184948
Study Section
Pathology A Study Section (PTHA)
Project Start
1998-07-15
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
3
Fiscal Year
2000
Total Cost
$446,862
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Zhang, LiFeng; Zalewski, Andrew; Liu, Yuchuan et al. (2003) Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108:472-8
Mazurek, Tomasz; Zhang, LiFeng; Zalewski, Andrew et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108:2460-6
Davenpeck, K L; Marcinkiewicz, C; Wang, D et al. (2001) Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circ Res 88:352-8
Shi, Y; Patel, S; Davenpeck, K L et al. (2001) Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation 103:2408-13
Shi, Y; Niculescu, R; Wang, D et al. (2001) Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21:739-45
Shi, Y; Niculescu, R; Wang, D et al. (2000) Myofibroblast involvement in glycosaminoglycan synthesis and lipid retention during coronary repair. J Vasc Res 37:399-407
Rodriguez, E; Lambert, E H; Magno, M G et al. (2000) Contractile smooth muscle cell apoptosis early after saphenous vein grafting. Ann Thorac Surg 70:1145-53
Patel, S; Shi, Y; Niculescu, R et al. (2000) Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation 101:524-32
Shi, Y; Patel, S; Niculescu, R et al. (1999) Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler Thromb Vasc Biol 19:1150-5
Mannion, J D; Ormont, M L; Magno, M G et al. (1998) Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts. Ann Thorac Surg 66:1948-52